Work

Maintenance of Clinical Efficacy After Dose Reduction of Ixabepilone Plus Capecitabine in Patients With Anthracycline- and Taxane-Resistant Metastatic Breast Cancer: A Retrospective Analysis of Pooled Data From 2 Phase III Randomized Clinical Trials

Year: 2012

Type: article

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2012.03.013

Authors: Vicente Valero, Eduard Vrdoljak, Binghe Xu, Eva Thomas, Henry Gómez, Alexey Manikhas, Carlos Medina, Rubi Khaw Li, Jungsil Ro, Linda Bosserman, Linda Vahdat, Pralay Mukhopadhyay, Diane Opatt, Joseph A. Sparano

Institutions: The University of Texas MD Anderson Cancer Center, Klinički Bolnički Centar Split, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Kaiser Permanente, Kaiser Permanente Oakland Medical Center, Instituto Nacional de Enfermedades Neoplásicas, City Clinical Oncology Center, Centro Médico Sanitas Córdoba, St. Luke's Medical Center, National Cancer Center, Weill Cornell Medicine, Bristol-Myers Squibb (United States), Montefiore Medical Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2161909068

FWCI: 0.426

Cites: 23

Cited by: 11

Related to: 10